Magnesium Sulfate Truncation in Severe Preeclampsia with Hemolysis, Elevated Liver Enzymes, Low Platelet Count (HELLP)-Associated AKI: Balancing Toxicity Risk and Seizure Prophylaxis
Journal of the American Society of Nephrology · 2026-10 · 37 (10S)
DOI: 10.1681/asn.2026rtb2xp12 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the American Society of Nephrology, 2026-10. Verfasst von Muhammed Khalifa und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Khalifa, M., Ibrahim, A., Gad, A., Mekki, O., Puscar, C., & Kwakye, K. A. (2026). Magnesium Sulfate Truncation in Severe Preeclampsia with Hemolysis, Elevated Liver Enzymes, Low Platelet Count (HELLP)-Associated AKI: Balancing Toxicity Risk and Seizure Prophylaxis. Journal of the American Society of Nephrology, 37(10S). https://doi.org/10.1681/asn.2026rtb2xp12
Vancouver
Khalifa M, Ibrahim A, Gad A, Mekki O, Puscar C, Kwakye KA. Magnesium Sulfate Truncation in Severe Preeclampsia with Hemolysis, Elevated Liver Enzymes, Low Platelet Count (HELLP)-Associated AKI: Balancing Toxicity Risk and Seizure Prophylaxis. Journal of the American Society of Nephrology. 2026;37(10S). doi:10.1681/asn.2026rtb2xp12
BibTeX
@article{Khalifa2026,
author = {Khalifa, Muhammed and Ibrahim, Abdelrahman and Gad, Ahmed and Mekki, Ossama and Puscar, Candela and Kwakye, Kwabena A.},
title = {Magnesium Sulfate Truncation in Severe Preeclampsia with Hemolysis, Elevated Liver Enzymes, Low Platelet Count (HELLP)-Associated AKI: Balancing Toxicity Risk and Seizure Prophylaxis},
journal = {Journal of the American Society of Nephrology},
year = {2026},
volume = {37},
number = {10S},
doi = {10.1681/asn.2026rtb2xp12}
}
EUVIMED